General Information
Revision date
2026-03-06
Product name
4-(3-Bromophenyl)morpholine hydrochloride
CAS No.
197846-83-6
supplier name
Combi-Blocks, Inc.
Emergency telephone
1-858-635-8950, 1-800-535-5053, 1-352-323-3500
Icons in SDS
Company Information
company name
Combi-Blocks, Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
sales@combi-blocks.com
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture FLAMMABLE LIQUIDS - Category 2 ACUTE TOXICITY (dermal) - Category 5 SKIN IRRITATION - Category 2 SERIOUS EYE DAMAGE - Category 1 CARCINOGENICITY - Category 1B TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 28.3% (oral), 64.9% (dermal), 34.5% (inhalation)
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapor. H313 - May be harmful in contact with skin. H315 - Causes skin irritation. H318 - Causes serious eye damage. H335 - May cause respiratory irritation. H336 - May cause drowsiness or dizziness. H350 - May cause cancer. H361 - Suspected of damaging fertility or the unborn child. H373 - May cause damage to organs through prolonged or repeated exposure. (hearing organs)
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing and eye or face protection. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P271 - Use only outdoors or in a well-ventilated area. P260 - Do not breathe vapor. P264 - Wash thoroughly after handling.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention. P304 + P340, P312 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P302 + P312 - IF ON SKIN: Call a POISON CENTER or doctor if you feel unwell. P332 + P313 - If skin irritation occurs: Get medical advice or attention. P305 + P351 + P338, P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor.
Storage
P405 - Store locked up. P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Other hazards which do not result in classification
Sanding and grinding dusts may be harmful if inhaled. Contains a substance that may emit formaldehyde if stored beyond its shelf life and/or during cure at curing temperatures greater than 60C ( 140F). Prolonged or repeated contact may dry skin and cause irritation. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Emits toxic fumes when heated. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
FLAMMABLE LIQUIDS - Category 2 substance or mixture ACUTE TOXICITY (dermal) - Category 5 SKIN IRRITATION - Category 2 SERIOUS EYE DAMAGE - Category 1 CARCINOGENICITY - Category 1B TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 28.3% (oral), 64.9% (dermal), 34.5% (inhalation)